These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32871137)

  • 1. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.
    Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z
    Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice.
    Ide S; Minami M; Ishihara K; Uhl GR; Satoh M; Sora I; Ikeda K
    Neuropharmacology; 2008 Jun; 54(8):1182-8. PubMed ID: 18417173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
    Schmidt BL; Tambeli CH; Levine JD; Gear RW
    Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive activity of a novel buprenorphine analogue.
    Lattanzi R; Negri L; Schmidhammer H; Giannini E
    Life Sci; 2002 Mar; 70(18):2177-85. PubMed ID: 12002809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
    Li JX; Becker GL; Traynor JR; Gong ZH; France CP
    J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
    Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.
    Wen Q; Yu G; Li YL; Yan LD; Gong ZH
    Acta Pharmacol Sin; 2011 Oct; 32(10):1215-24. PubMed ID: 21863064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.
    Taylor AM; Roberts KW; Pradhan AA; Akbari HA; Walwyn W; Lutfy K; Carroll FI; Cahill CM; Evans CJ
    Br J Pharmacol; 2015 Jan; 172(2):691-703. PubMed ID: 24923251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
    Yu G; Yue YJ; Cui MX; Gong ZH
    J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
    Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
    J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.